ABSTRACT: Enhanced glycolysis and poor perfusion in most solid malignant tumors create an acidic extracellular environment, which enhances tumor growth, invasion, and metastasis. Complex molecular systems have been explored for imaging and treating these tumors. Here, we report the development of a small molecule, LS662, that emits near-infrared (NIR) fluorescence upon protonation by the extracellular acidic pH environment of diverse solid tumors. Protonation of LS662 induces selective internalization into tumor cells and retention in the tumor microenvironment. Noninvasive NIR imaging demonstrates selective retention of the pH sensor in diverse tumors, and two-photon microscopy of ex vivo tumors reveals significant retention of LS662 in tumor cells and the acid tumor microenvironment. Passive and active internalization processes combine to enhance NIR fluorescence in tumors over time. The low background fluorescence allows tumors to be detected with high sensitivity, as well as dead or dying cells to be delineated from healthy cells. In addition to demonstrating the feasibility of using small molecule pH sensors to image multiple aggressive solid tumor types via a protonation-induced internalization and retention pathway, the study reveals the potential of using LS662 to monitor treatment response and tumor-targeted drug delivery.
■ INTRODUCTION
Aggressive solid tumors utilize enhanced glycolysis for energy production and proliferation, leading to a net increase in intracellular protons relative to that in healthy cells. To remain viable at a normal physiological intracellular pH (pHi) of 7.4, cancer cells actively pump out the excess protons. 1 However, the poor lymphatic function and chaotic vascularization of tumors result in an inefficient buffering or removal of the effluxed protons, leading to a significant reduction in extracellular pH (pHe) from 7.4 to 6.2−6.9.
1,2
Previous studies have demonstrated that the acidic pHe of solid tumors correlates with an increase in tumor invasiveness and cell proliferation, as well as a decrease in chemotherapeutic efficacy. 1,3−6 The therapeutic effect of modulating the acidic pHe was demonstrated in preclinical models by oral administration of sodium bicarbonate, which systemically neutralized the pHe of the whole body, including tumors. The systemic neutralization reduced tumor burden and decreased the number of circulating tumor cells. 3,4,7−9 These results suggest that the acidic pHe of solid tumors is not only a byproduct of mitochondrial dysfunction and enhanced glycolysis 10 but also represents an important survival pathway that supports tumor growth and metastasis. Thus, the ability to noninvasively image the pHe of tumors affords new means to determine the aggressiveness and severity of cancer or to monitor treatment response. A variety of molecular imaging probes and nanoparticles have been developed for in vivo imaging of pH changes. 2,11−14 Although chemical exchange saturation transfer (CEST) enhanced magnetic resonance imaging provides depthindependent assessment of pH in vivo, the method requires long acquisition times 15 and the use of a high concentration of the CEST contrast agent. 16 For small animal imaging or the assessment of superficial and endoscopically accessible tumors, optical methods represent a high-throughput imaging platform for real-time image display 17 and detection of pH changes in vivo via multiple contrast-generating molecular probe designs.
An interesting approach is the wide use of activatable molecular probes to amplify the signal-to-background ratio.
This approach has been used successfully to report enzyme activities, 18 −24 intracellular pH, [11] [12] [13] 25 and intracellular levels of reactive oxygen species. 26 To combine targeted delivery with fluorescence enhancement in vivo, recent studies have conjugated pH-sensitive dyes to tumor-targeting ligands such as RGD peptides, 11 where the progressive pH decrease along the endocytotic pathway culminates into high fluorescence in the lysosomes of tumor cells. 11−13 The pK a of pH sensors can be tuned to minimize background fluorescence in nonacidic cell compartments or tissue environments. However, tumor heterogeneity dictates significant variability in the expression of the targeted proteins in tumor cells. When pH sensors are conjugated to tumor-targeting ligands, the primary mode of fluorescence enhancement for the pH sensors is through intracellular acidic organelles, with limited access to the acidic extracellular tumor environment.
In this study, we have developed a pH-sensitive molecule, LS662, for noninvasive imaging of the acidic pHe of solid tumors. We demonstrate that protonation of the small NIR fluorescent molecule (∼700 Da) in the mildly acidic environment of diverse solid tumor types induces an absorption spectral shift from the visible to the NIR region. We used the ensuing NIR fluorescence to successfully identify three different tumor models, including syngeneic and spontaneous murine and human xenograft tumors. The selective retention of LS662 in tumor cells and the acidic environment for over 3 days suggests that protonation traps the small molecule and facilitates its internalization in cancer cells without conjugating the dye to a tumor-targeting protein or peptide. 11 This study demonstrates the potential use of LS662 for interrogating physiologic parameters in a broad range of cancers.
■ MATERIALS AND METHODS
Materials. All chemicals were purchased from SigmaAldrich (St. Louis, MO, USA) and were used without further purification. 1 H NMR data were recorded on a Varian 400 MHz spectrometer (Palo Alto, CA, USA) at ambient temperature in DMSO-d 6 and referenced to tetramethylsilane (TMS) as an internal standard. Mass-spectrometry was recorded on a Shimadzu LCMS2010 ESI-TOF mass Spectrometer (Columbia, MD, USA).
Dulbecco's modified Eagle's medium (DMEM) culture medium, fetal calf serum, and penicillin−streptomycin were purchased from Gibco (Life Technologies, NY, USA). Vectashield was purchased from Vector Laboratories (CA, USA).
Human epidermoid cancer (A431) cells were obtained from ATCC (VA, USA), and 4T1/luc murine breast cancer cells were obtained from David Piwnica-Worms, Washington University in St. Louis. 27 Cells were cultured using DMEM supplemented with 10% FBS and 1% penicillin−streptomycin in a humidified incubator at 5% CO 2 balanced with air at 37°C. The cells were kept at 50−80% confluence.
Female BALB/c and female athymic NCr-nu/nu mice were obtained from Charles River Laboratories (MA, USA). Female PyMT mice were bred in-house. All animal studies were performed with accordance with protocols approved by the Washington University School of Medicine Animal Studies Committee.
Synthesis of pH-Sensitive NIR Fluorescent Dye LS662. The synthesis of LS662 is summarized in Figure 2A . A mixture of Vilsmeier reagent 1 (1.1 g, 3 mmol) and 4-carboxylphenyboronic acid (1 g, 6 mmol) was heated overnight under reflux in DMF in the presence of potassium acetate (66 mg, 0.69 mmol) and tetrakis(triphenylphosphine)palladium(0) (0.22 g, 0.19 mmol). The reaction mixture was allowed to cool to room temperature, and DMF was evaporated. HPLC purification of product 2 afforded 0.67 g of a blue-green solid (55% yield). A mixture of indolenium sulfonate 3 (100 mg, 0.38 mmol) and Suzuki product 2 (73 mg, 0.18 mmol) was heated under reflux in the presence of sodium acetate (55 mg, 0.67 mmol) in 10 mL of an ethanol/acetic anhydride solution (50/50, v/v) for 20 h. After cooling, 2 mL of a 3% aqueous HCl solution was added to the resultant mixture. The crude product was purified by reverse-phase C-18 column chromatography, and the desired compound was eluted with CH 3 Spectral Properties and pK a of LS662. The absorption and emission spectra of LS662 were recorded on a spectrophotometer (Beckman DU640, CA, USA) and fluorometer (Fluorolog-3, Horiba Jobin Yvon, NJ, USA), respectively. Determination of the absorption and emission maxima was reported in solutions with pH values below and above 5. The fluorescence quantum yield of LS662 in PBS was determined by using a literature method and referenced to indocyanine green dye. 11 For pH titrations, LS662 was dissolved in 30 mL of water. 175 mg of NaCl (0.003 mmol) was added to provide a relative constant ionic strength of 0.1 M. The initial solution was acidified with dilute aqueous HCl (0.1 M) to achieve a pH of 2.34. Increment changes of the pH value were achieved by adding a small amount of dilute NaOH (vary from 0.1 to 0.0001 M) into the dye solution. The pH of the solutions was measured with a pH meter (Accumet AB15, MA, USA). At each pH point, the absorption and fluorescence spectra were recorded. The pK a of LS662 was determined using sigmoidal dose−response curve fitting software (GraphPad Prism 5.0, CA, USA).
To obtain optical images of the dye at pH 6.0 and 6.5, 2-(Nmorpholino)ethanesulfonic acid (MES; 1 M) was prepared in water and titrated with NaOH to the appropriate pH. For pH 7.0 and 7.5 medium, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES; 1 M) was prepared in water and titrated with HCl or NaOH to the appropriate pH. These solutions were diluted with phenol red-and bicarbonate-free DMEM to obtain a final concentration of 20 mM. LS662 (10 μM) was dissolved in each solution (100 μL) in a 96-well plate and imaged on the Pearl NIR fluorescence imaging system, ex/em 785/820 nm (LICOR Biosciences, NE, USA).
Blocking and pH Variable Internalization. A431 cells were grown in 96-well plates (BD Biosciences, NJ, USA). The cells were treated with 1 μM LS662 for 1−8 h in either acidic (pH 6.4) or neutral (pH 7.4) medium. Acidic medium was made by adding 25 μL of 1 M HCl per 1 mL of medium. For blocking studies, 10 mM sodium azide, an active transport inhibitor, was coincubated with the cells. After treatment, the cells were rinsed with PBS and imaged using a BX-51 epifluorescent microscope (Olympus, PA, USA). A cy5 U-N41008 (Chroma Technology Corp., VT, USA) filter cube was used for excitation at 620/60 nm and emission collection at 700/75 nm.
4T1/luc cells were grown in an 8-well slide (BD Biosciences, NJ, USA). The cells were treated with 10 μM LS662 or 1 μM cypate for 2 or 8 h in either acidic (pH 6.4) or neutral (pH 7.4)
Molecular Pharmaceutics
Article medium. After treatment, the cells were rinsed with acidic or neutral medium and imaged using a FV1000 confocal microscope with an UPLanApo/IR 60×/1.20W water immersion objective lens (Olympus, PA, USA) at 633 nm (LS662) or 785 nm (cypate) excitation, and fluorescence was detected at 690/50 nm (LS662) or 850 LP (cypate).
Cell Death Assay. A431 cells were grown on 8-well microscope slides (BD Biosciences, NJ, USA). To determine if LS662 preferentially stains dead cells, three conditions of A431 cells were incubated with 1 μM LS662 or 1 μM cypate for 2 h: healthy cells (cell in medium with LS662), dying cells (cell incubated with PBS with LS662), and dead cells (cell pretreated with 50% ethanol in PBS for 30 min, with LS662 added after the treatment with ethanol). After treatment, the cells were rinsed with PBS, mounted with Vectashield (Vector Laboratories, CA, USA), and coversliped. The slides were imaged using a FV1000 confocal microscope with an UPLanApo/IR 60×/1.20W water immersion objective lens (Olympus, PA, USA) at 633 nm (LS662) or 785 nm (cypate) excitation, and fluorescence was detected at 690/50 nm (LS662) or 850 LP (cypate).
Induction of Tumors in Murine Models. All animal studies were performed in accordance with protocols approved by the Washington University School of Medicine Animal Studies Committee. Syngeneic 4T1/luc murine breast tumors were initiated in mice by injecting 5 × 10 5 4T1/luc breast cancer cells subcutaneously in the right flank of 6−8 week old female BALB/c mice. Imaging studies were performed after the tumors had grown for approximately 10 days to a size of 5−7 mm in diameter. A431 human epithelial carcinoma xenografts were grown in 6−8 week old female athymic NCr-nu/nu mice by bilaterally injecting A431 cells into the mammary fat pad. Imaging studies were conducted after tumors had grown for approximately 15 days to a size of 5−7 mm in diameter. The spontaneous breast cancer mouse model, expressing the polyomavirus middle T antigen via the mouse mammary tumor virus long terminal repeat promoter (PyMT), was bred in-house. Heterozygous mice developed spontaneous, multifocal mammary adenocarcinomas at about 8−12 weeks of age.
In Vivo and ex Vivo Tumor Imaging. LS662 or cypate was dissolved in DMSO and then diluted with PBS for a final concentration of 60 μM in 100 μL of 20% DMSO and 80% PBS. The solution was injected intravenously via the lateral tail vein. Fluorescent imaging was performed using the Pearl NIR fluorescence imaging system (ex/em 785/820 nm) before injection and at 1, 2, 4, 6, 24, 48, and 72 h postinjection. After 72 h, the mice were euthanized, and organs of interest were removed, placed on a Petri dish, and imaged with the Pearl imager. Region of interest (ROI) analysis was performed with Pearl imaging software. The mean fluorescence intensities were measured for each tissue to assess the biodistribution of each compound. In addition, in vivo ROIs for tumor and normal tissues were used to determine the accumulation of the probe over time. The normal tissue regions were chosen that did not include any excretory organs or tumors in order to obtain a reliable background measurement.
Ex Vivo Multiphoton Imaging. After excision, tumors were cut into 1 mm slices and imaged using a custom built twophoton microscope at the Washington University School of Medicine. The visible emission from LS662 was excited with a Chameleon XR Ti-Sapphire laser (coherent) and visualized with an Olympus XLUMPlanFl 20× objective (water 
Article immersion, NA 0.95). Fluorescence emission from collagen, elastin, and LS662 was separated using 515 and 560 nm dichroic mirrors and detected using the red (560−650 nm), green (490−560 nm), and blue (second harmonic <458 nm) channels of three-head-type Bialkali photomultiplier tubes. 28, 29 z-stack images were acquired by taking 20 sequential images at a step size of 2.5 μm, and 15 video rate frames were averaged for each z-slice. Imaris (Bitplane, MA, USA) and ImageJ (NIH, MD, USA) were used for multidimensional rendering. 30 Histological Analysis. Excised tumor tissues were flashfrozen in OCT (Tissue Tek, CA, USA) and stored at −20°C. The tumors were sliced at a thickness of 10 μm (Cryocut 1800, IL, USA). Fluorescence imaging was performed with an Olympus BX51 upright epifluorescent microscope (Olympus America, PA, USA). A cy5 U-N41008 (Chroma Technology Corp., VT, USA) filter cube was used for excitation at 620/60 nm and emission collection at 700/75 nm. Muscle samples, taken from the mouse's left leg, were imaged with the above settings as non-tumor control samples. To confirm that lack of LS662 fluorescence was not due to inactivation, acidic PBS (pH 4.0) was added to the sample to activate any LS662. H&E staining of excised tumor and surrounding tissues was used for histologic validation of tissue types.
Statistical Analysis. All cell studies were performed in triplicate. The mean fluorescence per image was calculated after background fluorescence subtraction and normalized to the number of cells per image. These values were then averaged, and error bars represent the standard deviation. For in vivo quantification of fluorescence of tumor and normal tissues, the following numbers of replicates were used: three for 4T1/luc tumor and normal, two for A431 tumor and three for A431 normal, and three for PyMT tumor and normal. For ex vivo quantification of tumor and muscle fluorescence, the following numbers of replicates were used: three for 4T1/luc tumor and muscle, two A431 tumor and one for A431 muscle, and three for PyMT tumor and one for PyMT muscle. When more than three replicates were present, the standard deviation was calculated and is displayed as error bars. Statistical significance was calculated using Student's t-test, and p-values less than 0.05 were considered to be statistically significant.
■ RESULTS
Synthesis and Spectral Properties of pH-Sensitive NIR Fluorescent Dye LS662. We have developed LS662 as a pHsensitive small molecule for identifying tumors. Upon protonation in acidic media, the molecule undergoes a significant spectral shift from visible to NIR wavelengths. The high NIR fluorescence is useful for identifying diverse tumors ( Figure 1 ).
LS662 was synthesized by modifying our previously reported method (Figure 2A) . 11 To overcome the low yields of this synthesis, we used modified Suzuki-coupling conditions in which Vilsmeier reagent 1 was reacted with 4-carboxyphenylboronic acid in the presence of tetrakis(triphenylphosphine)-palladium(0) and anhydrous potassium acetate. Purified LS662 was obtained as blue-green solid. The dye is stable in powder 
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Article form; although the aqueous solution can be stored at 4°C for several weeks, it is best to use freshly prepared solutions for each study. pH titration showed that LS662 has low NIR fluorescence in basic and neutral solutions, displaying an absorption maximum (λ abs ) at 503 nm ( Figure 2C) . A significant hypsochromic shift from 503 to 750 nm λ abs and an intense NIR emission maximum (λ em ) at 768 nm were observed in acidic solutions (pH < 6), with corresponding pK a , molar absorptivity (ε), and fluorescence quantum yield (Φ F ) of 5.2, 120 000 M −1 cm
, and 0.025, respectively, in PBS. Protonation of one indolenium ring nitrogen in LS662 converts the molecule into a donor−acceptor fluorophore system, which exhibits a large spectral shift. 11 Pseudocolor fluorescence images of LS662 solutions in buffers of different pH demonstrate the visual changes in fluorescence intensity that take place with increasing pH ( Figure 2D ).
LS662 Differentially Internalizes in Tumor Cells via Dual ATP-Dependent and -Independent Pathways in Neutral and Acidic Culture Media. We postulated that protonation of LS662 under mild acidic conditions found in the pHe of many solid tumors will decrease the molecule's net negative charge, enhance NIR fluorescence, and facilitate internalization in cells. To test this hypothesis, LS662 was incubated with representative tumor cells (A431 or 4T1/luc) in buffer solutions at pH 7.4 and 6.4 to simulate normal physiological and acidic tumor pHe values, respectively ( Figure  3A) . At pH 7.4, only a few cells exhibited high NIR fluorescence within a 2 h incubation. Longer incubation times showed weak and diffuse NIR fluorescence in nearly all cells. A similar trend was observed in acidic solutions, in which the internalization of LS662 occurred in only a few cells within a 2 h incubation, but it increased significantly at the 8 h measurement time point. The few cells exhibiting high NIR fluorescence within 2 h in both normal and acidic media are probably dying or dead cells. From a structural consideration alone, internalization of the highly negatively charged LS662 into cells at neutral pH would not be expected because of electrostatic repulsion from the cell membrane's phosphate groups. Therefore, the delayed but significant accumulation of the molecular probe in cancer cells at long incubation times suggests a molecular rearrangement that facilitates passive or active transport in cells. Compared with cells treated at pH 7.4, fluorescence of LS662 was significantly higher under acidic conditions. This internalization process could be mediated by electrostatic interactions of protonated LS662 with the phosphate groups in cell membranes ( Figure 1D ). As a control, a less physiologically pH-sensitive dye cypate ( Figure 2B ) 31 was also incubated with 4T1/luc cells. As expected, the internalization of cypate was not pH-dependent ( Figure 3B) .
To investigate the mechanism of LS662 internalization, we incubated A431 or 4T1/luc cells with the pH sensor in acidic (pHe 6.4) and neutral (pHe 7.4) media in the presence or absence of sodium azide, an active transport inhibitor ( Figure  3A) . 32, 33 In both acidic and neutral solutions, cells treated with sodium azide exhibited lower NIR fluorescence than that of the untreated control. However, the decrease in LS662 fluorescence was higher under neutral (77% A431, 32% 4T1/luc) conditions at 8 h postincubation than it was under acidic conditions (13% A431, 9.5% 4T1/luc) ( Figure 3B ). This finding suggests that the highly negatively charged, nonprotonated LS662 overcomes electrostatic repulsion at the plasma membrane via an active transport process. In the protonated form, ATP-independent endocytosis is the dominant mechanism of LS662 internal- Because the NIR fluorescence of LS662 is weak under neutral pH, the high intracellular fluorescence most likely occurred through the acidic endosomal pathway or by translocation into acidic intracellular organelles. Coincubating LS662 with a lysosomal reporter, lysotracker green, showed that the punctate LS662 fluorescence colocalized with the lysotracker dye, indicating that LS662 is in the acidic lysosomes ( Figure 3D ).
LS662 Is a Highly Sensitive Reporter of Dying and Dead Cells. Regardless of the treatment conditions, some cells exhibited bright LS662 fluorescence within 2 h postincubation, suggesting that the molecular probe could serve as reporter of cell death. To explore this capability, A431 cells were incubated with LS662 for 2 h under three different conditions, normal culture media, PBS solution, or 50% ethanol in PBS, to obtain predominantly healthy, dying, and dead cells, respectively ( Figure 3C ). Cypate was incubated with cells under similar conditions ( Figure 3C ). As cells die, a 5000-fold increase in LS662 fluorescence was observed, whereas the fluorescence from cypate only showed a moderate 2-fold increase. The small increase in cypate fluorescence could be attributed to nonspecific uptake in dead cells.
Previous studies have shown that cells undergoing necrosis or apoptosis are characterized by the disruption of their organelles' membranes, leading to the release of their contents and acidification of the cytosol, with fewer residual intact lysosomes. 14, 34, 35 Thus, the high increase in LS662 fluorescence in dead or dying cells suggests protonation of the molecule under the mild intracellular acidic conditions of these cells ( Figure 3C ). Loss of intracellular membrane integrity transforms the highly punctate LS662 fluorescence to a more diffuse intracellular pattern. These results illustrate the multidimensional use of LS662 to localize tumors and possibly to identify dying cells in response to treatment.
Protonation of LS662 Enhances NIR Fluorescence in Mouse and Human Cancer Models. The primary goal of this study was to evaluate the feasibility of imaging diverse solid tumors using the simple pH-sensitive molecular probe in vivo. Starting with subcutaneous 4T1/luc tumors in the flanks of mice, fluorescence of LS662 in the tumor region was evident as early as 1 h postinjection, attaining maximum contrast at 72 h (Figure 4Ai,ii) . The high tumor tissue-selective contrast was confirmed by ex vivo imaging and region of interest analysis of the tumor, with a tumor-to-muscle contrast of 15.7 ± 0.3 ( Figure 4Aiii ). The high fluorescence in the kidneys and liver suggests a bimodal excretion route for LS662. As a small hydrophilic molecule, renal excretion was expected. The 
Article significant hepatobiliary excretion indicates that a fraction of the dye was bound to blood proteins, which then presents the molecules to the liver for subsequent excretion. The widely used NIR fluorescent dyes, ICG and cypate, are excreted from the body by a similar hepatobiliary pathway ( Figure 4D ). 36, 37 Low uptake in the spleen and lungs suggests minimal aggregation of the molecular probe in vivo.
We compared the uptake of the pH-sensitive dye with that of cypate, a similar cyanine dye exhibiting less pH responsiveness. 31, 38 Longitudinal imaging of cypate in 4T1/luc tumorbearing mice showed rapid clearance from the body within 1 h postinjection. The fluorescence of cypate was barely detectable after 24 h postinjection ( Figure 4D ). Quantitative image analysis shows that there is no selective accumulation or retention of cypate in tumors. A similar result using cypate was obtained with LS798. This compound is structurally similar to LS662, but its fluorescence and absorption spectra do not respond to pH changes in the physiologically relevant range of pH 4−8 (see Supporting Information). These results lend credence to the use of simple and small pH-sensitive NIR fluorescent dyes to interrogate the acidic milieu of solid tumors.
Having demonstrated that LS662 can localize in the acidic environment of a subcutaneously implanted murine mammary tumor model, we extended this imaging approach to the human-origin A431 tumor xenograft model ( Figure 4B ). The tumor cells were grown bilaterally in the mammary fat pads of athymic nude mice. Administration of LS662 in tumor-bearing mice and subsequent fluorescence imaging showed a rapid clearance of the dye from blood and other tissues. At 1 h postinjection, high fluorescence in the bladder was observed, probably due to the low pH of urine. Although the initial fluorescence was low, the accumulation and activation of LS662 in the tumor were evident as early as 1 h postinjection, culminating in maximum tumor-to-normal tissue contrast at 72 h postinjection. This temporal increase suggests that nonfluorescent LS662 remained in circulation or was already trapped in the tumor and became fluorescent with continuous protonation of the molecules. A tumor-to-muscle contrast of 14.30 ± 0.03 was determined ex vivo from the excised organs (Figure 4Biii) .
Subcutaneously implanted tumor models do not fully recapitulate the biologic and histopathologic features of human cancers. Therefore, we explored the applicability of this approach in the PyMT spontaneous murine breast cancer model. PyMT mice are immunocompetent and present aspects of human breast cancer that are not represented by xenograft models. The similarities include spontaneous tumor development and the complex interaction of immune cells within the tumor. Intravenous administration of LS662 and fluorescence imaging showed rapid hepatobiliary clearance within 1 h postinjection of LS662 ( Figure 4C ). This enhanced excretion pathway illustrates the variability in biodistribution that can be induced in different animal models. In this model, liver uptake was favored compared to the renal excretion observed in the 
Article subcutaneous tumor models ( Figure 4A,B) . Low fluorescence was observed in the tumors around the mammary fat pads, becoming more evident at 4 h before plateauing after 24 h postinjection (Figure 4Cii ). This model also shows lower tumor-to-muscle contrast (3.46 ± 0.19) than that of the 4T1/ luc and A431 tumor models. It is likely that the multifocal nature of the PyMT tumors prevented secreted protons from being locally concentrated, as seen in the other tumors, which could minimize the extent of pHe reduction from normal physiologic pHe. In spite of relatively low tumor-to-background contrast, histologic analysis of excised tissue showed that LS662 was able to detect multiple small tumors.
Two-Photon Imaging and Fluorescence Histology Reveal Punctate and Diffuse Intratumoral Distributions of LS662. The planar NIR fluorescence imaging system that we used to acquire the in vivo images is a surface-weighted lowresolution device. To determine the distribution of LS662 in the tumor microenvironment, we used high-resolution twophoton fluorescence and second harmonic generation microscopy for the study. 3D reconstruction of a freshly excised 4T1/ luc tumor after LS662 injection revealed a chaotic structure of collagen (blue) and elastin (green) that surround and form the 4T1/luc tumor matrix ( Figure 5A ). LS662 (red) is distributed in the diffuse extracellular region just interior to the tumor capsule and is localized with fibrous bundles surrounding and inside the tumor. A depth of up to 100 μm was imaged, which is a typical penetration depth for two-photon microscopy. 39 After two-photon imaging, the tumor was frozen in OCT and sectioned for histology. Imaging of the same region shows LS662 fluorescence originating from cellular regions of the tissue ( Figure 5A, right) . The two-photon images demonstrated that LS662 is able to interrogate the extracellular matrix (ECM) of tumors, with a significant fraction specifically internalizing into tumor cells.
Further analysis of the PyMT tumors via fluorescence histology shows that LS662 localized in specific cells and throughout the tumor stroma, supporting the findings from the 4T1/luc two-photon imaging ( Figure 5D ). We also found that a tumor-infiltrated lymph node displayed high LS662 fluorescence ( Figure 5E ). Muscle samples from the left leg of the mouse were obtained to evaluate the presence of LS662 in healthy tissue ( Figure 5F ). The absence of NIR fluorescence indicates that LS662 is not present in normal tissue, except the excretory organs. Acidification of the muscle tissue with PBS (pH 4.0) did not result in NIR fluorescence, indicating the absence of residual nonprotonated LS662 in healthy tissue.
■ DISCUSSION
Although it was previously considered to be a side product of enhanced glycolysis, acidification of the tumor environment appears to support tumor proliferation and metastasis of aggressive solid tumors. Earlier studies have demonstrated the potential of targeting this physiologic condition for cancer detection and treatment. 3, 4, 9, 40 For optical imaging, pHresponsive molecular designs include the conjugation of pH sensors to tumor-targeting groups such as peptides or antibodies. 11 Other pH sensor design strategies include the incorporation of pH-cleavable linkers into nanoparticle constructs, followed by the release of a high concentration of chemotherapeutics or imaging agents in solid tumors in vivo. 41, 42 Similarly, conjugation of multiple dyes to macromolecules via acid-cleavable linkers or loading of dyes into pHdegradable nanoparticles can quench dye fluorescence, which is activated upon degradation of the product under acidic conditions. 11, 16, 41 Previously, we demonstrated that conjugation of a pH sensor to an RGD peptide allowed tumors to be detected with high tumor-to-background fluorescence contrast. Fluorescence enhancement was generated only in intracellular compartments, similar to that reported using other receptortargeted approaches. 11 In this study, we explored the feasibility of using a simple and small pH-sensitive molecule to image the acidic pHe in vivo. By avoiding the complexity of nanoparticle formulations and conjugation of the pH-sensitive molecules with tumor-targeting agents, LS662 represents a viable alternative to current pH-sensing molecular probes. Because LS662 possesses intrinsic tumor-targeting and retention properties, we can conjugate drugs instead of tumor-avid ligands to the free carboxylic acid moiety for targeted therapy.
The pH in the extracellular environment of tumors is generally about 6.5, whereas the pH of blood and most nontumor tissues is approximately 7.4. Because LS662 is a weak acid with a pK a of 5.2, the Henderson−Hasselbalch equation can be used to estimate the percentage of protonated LS662 at pH 6.5 versus that at pH 7.4
where [A − ] and [HA] are the nonprotonated and protonated forms of LS662, respectively. Using the above equation, we expect 0.6 and 5% of protonated LS662 to be in the nontumor and tumor environments, respectively, representing an 8-fold increase of the protonated form in the acidic tumor environment.
We studied the relative fluorescence enhancement of LS662 in tumor versus nontumor tissues, including the in vivo kinetic analysis and ex vivo fluorescence biodistribution for all cancer models used (Figure 4) . Because pH-sensitive LS662 and less pH-sensitive cypate (in a physiologically relevant pH range) are not specifically targeted to tumor cells, we expect similar in vivo biodistribution profiles for both compounds. Therefore, the higher fluorescence intensity in the tumor tissues observed with LS662 is attributed to pH-dependent protonation of the dye. LS662 has a pK a of 5.2 and exhibits low fluorescence above pH 7, which provides low background signal. Although these characteristics improved the tumor-to-surrounding tissue contrast, only a small fraction of LS662 is protonated between pH 6 and 7. Increasing the proportion of the protonated form of the dye in the acidic environment of tumors will improve both the tumor-to-nontumor contrast and net signal (fluorescence intensity). One approach to accomplish this goal is to develop or use a NIR fluorescent pH-sensitive dye possessing a pK a of about 6.5 and negligible fluorescence above pH 7.2.
LS662 appears to accumulate and internalize in tumor cells by a bimodal pathway. In the nonprotonated form, the highly negatively charged molecules undergo ATP-dependent endocytosis. Although the exact mechanism of internalization is not known at this time, intracellular punctate fluorescence suggests an endosomal pathway that acidifies the molecules as they transit from early (higher pH) to late (lower pH) endosomes/ lysosomes. In contrast, protonation of LS662 appears to facilitate internalization by a process that is less dependent on active transport. We postulate that the positively charged LS662 interacts electrostatically with the phosphate groups on the cell membrane to induce internalization by energy-dependent and -independent mechanisms, similar to that of HIV tat-peptides or amphiphilic polymers. 43 ,44
Molecular Pharmaceutics
Article Internalization of both protonated and nonprotonated forms of LS662 in cells by different mechanisms could lead to sporadic uptake of this molecular probe in many cells in vivo. However, our small animal imaging results indicate that it has high tumor selectivity, as demonstrated in three different cancer models. Accumulation in both the extracellular acidic space and in tumor cells provides a two-prong reporting strategy in which relatively weak fluorescence in tumors from molecules protonated in the extracellular space is visible within 1 h, followed by highly intense fluorescence induced by both intraand extracellular protonation of LS662. Two-photon and SHG imaging also show that LS662 does not stain elastin and collagen fibers in the tumor matrix, a further indication of pHassociated selective uptake in tumor tissue.
Accurate sensing of pHe in vivo could be advantageous in monitoring tumor growth and cell death during therapy. Our results show that LS662 accumulates in a variety of cancer models, regardless of the tumor's origin. Comparison of LS662's uptake in these tumor models suggests that LS662 fluorescence may correlate with the differences in pHe and the distribution of the excreted protons (Figure 4 ). Diffuse and invasive tumors such as PyMT 45 release protons into a large tissue volume, which could result in a more neutral physiologic pHe than that of implanted tumors, such as 4T1/luc and A431, which could exhibit a lower pHe because protons are released in a small, encapsulated tissue volume. If it is validated with reference standards, the relative fluorescence of LS662 could be used to correlate tumor invasiveness and metastatic potential with the size, proton distribution, type, and origin. 46, 47 Unlike SNARF-1, 47, 48 which requires its use in high concentrations for pH sensing in the visible-light region, the NIR emission of LS662 allows tumor tissues to be interrogated noninvasively in small animals with a higher detection sensitivity using a relatively lower dose of the molecular probe.
In summary, LS662 is a promising small molecule for reporting the cellular and extracellular pH of tumors. Its capacity to illuminate the tumors within 1 h, prolonged retention in tumors, and NIR fluorescence make it useful for diverse biomedical applications, including the targeted delivery of drugs. Low background NIR fluorescence before protonation improves tumor contrast in vivo. This molecular probe is also capable of sensing different stages of cell death, with over a 5000-fold fluorescence increase in dying and dead tumor cells because of the elevated acidity of necrotic or apoptotic tumor bodies. 34, 35 This work has unveiled a novel class of small molecules that can target diseased tissue simply through electrostatic changes produced by environmental factors.
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